시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계 액체 색전물질 시장 - 업계 분석, 규모, 점유율, 성장 및 동향 예측(2031년) : 제품별, 적응증별, 최종 사용자별, 지역별
Liquid Embolic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
상품코드 : 1420309
리서치사 : Fairfield Market Research
발행일 : 2024년 01월
페이지 정보 : 영문 280 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,995 ￦ 6,922,000
Unprintable PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.
US $ 8,495 ￦ 11,772,000
Unprintable PDF & Excel (Multi User License upto 5 users) help
PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.
US $ 10,600 ￦ 14,689,000
Printable PDF & Excel (Enterprise License above 5 users) help
PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 액체 색전물질 시장 규모는 2024년에 2억 7,000만 달러에 달할 것으로 보이며, 2031년까지 약 5억 8,050만 달러에 달할 것으로 예측되고 있으며, 연평균 성장률(CAGR)은 8.9% 되어 현저한 성장 궤도를 잡는 것으로 보입니다.

액체 색전 바이알은 현재 세계 시장에서 82.7%라는 큰 점유율을 차지하고 있습니다. 액상 색전 제품은 동정맥 기형의 치료에 사용되어 성공을 거두고 있지만, 동맥류 치료에의 적용은 주로 모혈관으로의 액체의 전이를 막는 우려로부터 일부 환자에게 한정 남아 있습니다.

세계의 액체 색전물질 시장은 지난 5년간 4.2%의 연평균 복합 성장률(CAGR)로 확대되었습니다. 색전술은 하나 이상의 혈관과 비정상적인 혈관 채널을 차단하는 데 사용되는 낮은 침습 치료입니다. 다양한 색전제가 카테터를 통해 혈관으로 도입되어 특정 부위로의 혈류를 억제합니다. n-부틸시아노아크릴레이트(NBCA) 및 에틸비닐알코올 공중합체와 같은 액체 색전물질는 색전 요법에서 중요한 역할을 합니다.

액체 색전물질 수요는 향후 10년간 상당한 비율로 급증할 것으로 예상되며 CAGR은 약 8.9%로 예측되고 있습니다. 이러한 성장은 2024년부터 2031년까지 3억 3,340만 달러의 기회 증가를 가져올 것으로 예상됩니다. 액체 색전 바이알은 액체 프리필드 주사제와 비교하여 예측 기간 동안 높은 수요를 유지할 것으로 예상됩니다.

종양 색전술은 전 세계적으로 종양 발생률이 증가하고 있기 때문에 액체 색전물질 제조업체에게 큰 기회가 되었습니다. 이 낮은 침습 수술은 종양으로의 혈액 공급을 차단하거나 종양을 죽이는 치료제를 종양에 직접 투여합니다.

본 보고서에서는 세계의 액체 색전물질 시장에 대해 조사했으며,, 시장 개요와 함께 제품별, 적응증별, 최종 사용자별, 지역별 동향 및 시장 진출기업의 경쟁 동향 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

제3장 생산고와 무역통계(2018-2023년)

제4장 가격 분석(2018-2023년)

제5장 세계의 액체 색전물질 시장 전망(2018-2031년)

제6장 북미의 액체 색전물질 시장 전망(2018-2031년)

제7장 유럽의 액체 색전물질 시장 전망(2018-2031년)

제8장 아시아태평양의 액체 색전물질 시장 전망(2018-2031년)

제9장 라틴아메리카의 액체 색전물질 시장 전망(2018-2031년)

제10장 중동 및 아프리카의 액체 색전물질 시장 전망(2018-2031년)

제11장 경쟁 구도

제12장 부록

JHS
영문 목차

영문목차

The global liquid embolic market, valued at US$ 270 million in 2024, is set to experience a significant growth trajectory, with a projected Compound Annual Growth Rate (CAGR) of 8.9% to reach a market valuation of approximately US$ 580.5 million by 2031, according to a recent market analysis by Fairfield Market.

Liquid Embolic Vials Dominate Market Share

Liquid embolic vials currently hold a substantial share of 82.7% in the global market. While liquid embolic products have been successfully used in the treatment of arteriovenous malformations, their application in aneurysm treatment remains limited to a select group of patients, primarily due to concerns about preventing the migration of the liquid to the parent vessel.

Demand Analysis and Growth Prospects

The global market for liquid embolics has expanded at a CAGR of 4.2% over the past five years. Embolization is a minimally invasive procedure used to block one or more blood vessels or abnormal vascular channels. Various embolic agents are introduced through catheters into blood vessels to inhibit blood flow to specific areas, with liquid embolic agents such as n-Butyl Cyanoacrylate (NBCA) and ethyl vinyl alcohol copolymers playing a vital role in therapeutic embolization.

The demand for liquid embolic products is expected to surge at a substantial rate over the next decade, with a projected CAGR of around 8.9%. This growth is anticipated to bring about an incremental opportunity of US$ 333.4 million from 2024 to 2031. Liquid embolic vials are expected to remain in high demand throughout the forecast period compared to liquid prefilled injectables.

Key Opportunities for Liquid Embolic Product Manufacturers

Tumor embolization presents a significant opportunity for liquid embolic product manufacturers, given the increasing incidence of tumors worldwide. This minimally invasive procedure involves shutting down the blood supply to tumors or delivering tumor-killing therapy directly to them.

Companies developing liquid embolic agents could expand their market share by pursuing regulatory approvals for indications beyond neuro interventional, tapping into the rising prevalence of cancer. Additionally, the growing demand for neurovascular embolization devices, driven by an increasing prevalence of cerebral aneurysms, offers further market growth prospects.

Advancements in research and development also provide opportunities for both emerging and established liquid embolic product suppliers to establish a strong presence in the market.

Factors Restraining Demand for Liquid Embolic Systems

While the demand for liquid embolic products is on the rise, certain challenges must be addressed. These include issues such as balloon deflation, catheter entrapment, and difficulties in deploying the device to the targeted lesion. Moreover, the high risk associated with liquid embolic procedures, including the potential of targeting the wrong blood vessels during surgical procedures, is a concern.

Additionally, limited liquid embolic agent manufacturers face intense competition from alternative transcatheter embolization devices, which could potentially restrain the growth of the liquid embolic systems market.

Country-wise Insights

The U.S.: Largest Regional Liquid Embolic Market

The United States dominates the North America liquid embolic market, with a substantial market share. This dominance is driven by factors such as unhealthy lifestyle habits, including junk food consumption, smoking, and alcohol use, as well as a sedentary lifestyle. These habits have led to a higher prevalence of chronic diseases like high blood pressure, migraines, and bAVM, increasing the demand for liquid embolic products and agents in the U.S. Moreover, lifestyle changes have been associated with a significant percentage of cancer cases in the country, further contributing to the demand for such products.

Germany: A Lucrative Market in Europe

Germany is expected to be a prominent player in the European market for liquid embolics. This is primarily due to the substantial number of clinical trials and research conducted in the country, particularly in the field of cancer research. Germany boasts a significant number of research ethics committees, with active government involvement in healthcare and cancer-related research and innovation. This environment presents lucrative opportunities for suppliers of liquid embolic products to grow in the market.

South Korea: An Emerging Market

South Korea is an emerging market in the East Asia liquid embolic market. The country is witnessing substantial growth in this sector, mainly due to the increasing prevalence of cardiovascular diseases. For instance, coronary heart disease-related deaths in South Korea have been a significant concern. This growth in cardiovascular issues has led to a rising demand for liquid embolic products and is expected to continue to expand in the coming years.

Competitive Analysis

Leading liquid embolic product providers are adopting growth strategies such as new product launches, approvals, agreements, collaborations, and partnerships. These strategies are helping key stakeholders expand their geographic footprint and strengthen their existing product portfolios.

Key Companies Profiled:

Key Segments Covered in Liquid Embolic Industry Research

Liquid Embolic Market by Product

Liquid Embolic Market by Indication

Liquid Embolic Market by End User

Liquid Embolic Market by Region

Table of Contents

1. Executive Summary

2. Market Overview

3. Production Output and Trade Statistics, 2018 - 2023

4. Price Analysis, 2018 - 2023

5. Global Liquid Embolic Market Outlook, 2018 - 2031

6. North America Liquid Embolic Market Outlook, 2018 - 2031

7. Europe Liquid Embolic Market Outlook, 2018 - 2031

8. Asia Pacific Liquid Embolic Market Outlook, 2018 - 2031

9. Latin America Liquid Embolic Market Outlook, 2018 - 2031

10. Middle East & Africa Liquid Embolic Market Outlook, 2018 - 2031

11. Competitive Landscape

12. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기